A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Oral Presentations inflammatory disease, HER2, hormone receptors, tumor grade, previous adjuvant chemotherapy, and prior anthracyclines. CON-CLUSIONS: Early lymphocyte recovery is an independent outcome predictor after HDC in MBC pts receiving a graft with a high T-cell content. These observations support the role for the immune system in tumor control after transplant, and suggest that pre-or post-HDC inmmne strategies targeting post-transplant residual disease may prove worthwhile. MBC ptsdoi:10.1016/s1083-8791(03)80035-6 fatcat:us6nrckvujao5e3ack6ij5i5s4